Panel Discussion: Mechanisms, Targets, & Therapeutic Potential: Dissecting Exciting Opportunities to Drive Novel Therapeutic Strategies

Time: 11:00 am
day: Day Two


  • Dissecting causative genes and cellular processes involved in ALS pathogenesis to shape future directions of therapeutic development
  • C9orf72, SOD1 & TDP-43: mapping promising targets
  • Can we move the needle in genetically defined patient populations and translate learnings to patients with sporadic ALS?